APTN on OTC
ADAPTIN BIO, INC.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development | $1.8M | $1.8M |
| General and administrative | $3.6M | $745.3K |
| Total Operating Expenses | $5.4M | $2.6M |
| Loss from Operations | -$5.4M | -$2.6M |
| Interest expense | $72.7K | $341.0K |
| Loss on change in fair value of derivative liabilities | $6.3K | $17.1K |
| Loss (Gain) on extinguishment of debt | -$326.3K | $194.5K |
| Total Other Expense (Income), net | -$247.4K | $552.7K |
| Loss Before Provision for Income Taxes | -$5.2M | -$3.1M |
| Net Loss | -$5.2M | -$3.1M |
| Basic (in Dollars per share) | -$0.66 | -$0.96 |
| Diluted (in Dollars per share) | -$0.66 | -$0.96 |
| Basic (in Shares) | 7.8M shares | 3.2M shares |
| Diluted (in Shares) | 7.8M shares | 3.2M shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $459.2K | $34.1K |
| Prepaid expenses and other current assets | $160.0K | $11.5K |
| Total Current Assets | $619.2K | $45.5K |
| Deferred equity issuance costs | $193.9K | |
| Total Assets | $619.2K | $239.4K |
| Accounts payable- trade | $1.5M | $1.4M |
| Accrued expenses | $596.5K | $1.0M |
| Convertible notes payable, net of debt issuance costs and discounts | $1.2M | |
| Derivative liability arising from convertible notes payable | $545.0K | |
| Accrued interest | $134.9K | |
| Total Current Liabilities | $2.1M | $4.3M |
| Total Liabilities | $2.1M | $4.3M |
| Common stock, $0.0001 par value, 50,000,000 shares authorized, 8,655,829 and 3,249,999 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $866 | $325 |
| Additional paid-in capital | $7.8M | $23.8K |
| Accumulated deficit | -$9.3M | -$4.1M |
| Total Stockholders Deficit | -$1.5M | -$4.1M |
| Total Liabilities and Stockholders Deficit | $619.2K | $239.4K |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 |
| Preferred stock, shares authorized (in Shares) | 10.0M shares | 10.0M shares |
| Preferred stock, shares issued (in Shares) | 0 shares | 0 shares |
| Preferred stock, share outstanding (in Shares) | 0 shares | 0 shares |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 |
| Common stock, shares authorized (in Shares) | 50.0M shares | 50.0M shares |
| Common stock, shares issued (in Shares) | 8.7M shares | 3.2M shares |
| Common stock, shares outstanding (in Shares) | 8.7M shares | 3.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Loss | -$5.2M | -$3.1M |
| Amortization of debt issuance costs and discounts | $53.7K | $239.8K |
| Change in fair value of derivative liabilities | $6.3K | $17.1K |
| Loss (Gain) on extinguishment of debt | -$326.3K | $194.5K |
| Shares issued in exchange for services | $250.0K | |
| Stock-based compensation | $496.9K | |
| Prepaid expenses and other current assets | -$148.5K | -$11.5K |
| Accounts payable- trade | $496.9K | $1.1M |
| Accrued expenses | -$453.4K | $851.3K |
| Accrued interest | $14.2K | $101.3K |
| Net Cash Used In Operating Activities | -$4.8M | -$649.3K |
| Proceeds from issuance of convertible notes payable | $1.0M | |
| Repayment of notes payable- related party | -$275.0K | |
| Proceeds from issuance of common stock and warrants in private placements | $7.2M | |
| Payment of issuance costs related to private placements | -$1.7M | -$193.9K |
| Payment of debt issuance costs | -$127.5K | |
| Net Cash Provided By Financing Activities | $5.2M | $678.6K |
| Net Increase In Cash and Cash Equivalents | $425.1K | $29.3K |
| Interest | $9.6K | |
| Recapitalization of Unite Acquisition 1 Corp. accumulated deficit at time of the exchange | -$279.7K | |
| Common stock cancelled at the time of the exchange | $175 | |
| Convertible notes and accrued interest converted into common stock | $1.7M | |
| Forgiveness of accrued consulting fees by related parties | $345.9K |
Former names
- Unite Acquisition 1 Corp.Aug 10, 2023 to Feb 13, 20252
Recent filings
- Sep 10, 2026424B3 PROSPECTUS
- Sep 9, 2026EFFECT
- Aug 28, 2026S-1 REGISTRATION STATEMENT
- Aug 25, 20268-K CURRENT REPORT
- Aug 25, 2026424B3 PROSPECTUS SUPPLEMENT
- Aug 20, 2026424B3 PROSPECTUS SUPPLEMENT
- Aug 13, 202610-Q QUARTERLY REPORT
- Jul 22, 2026EFFECT
- Jul 21, 2026POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
- Jun 22, 2026D/A
- Jun 12, 202610-K/A AMENDMENT NO. 1 TO FORM 10-K
- Jun 12, 2026424B3 PROSPECTUS SUPPLEMENT
- May 18, 2026424B3 PROSPECTUS SUPPLEMENT
- May 15, 202610-Q QUARTERLY REPORT
- Apr 6, 20268-K CURRENT REPORT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7